Dr Nadeem Sarwar, Vice President and Global Head – Genetics & Human Biology; Director – Integrated Human Genomics (IHGx) Unit, Eisai Inc.
Time: Monday 15th September, 4pm
Venue: Thomas Strangeways room, Strangeway’s research laboratory (Addenbrooke’s campus)
Nadeem’s research focuses on applying several integrated sciences to deliver novel and targeted medicines from human genetics to patients. He has established and directs the “Integrated Human Genomics” (IHGx) Unit, which combines dedicated quantitative, wet-lab biology and chemistry expertise and resource within an autonomous and highly collaborative R&D innovation unit. He sits on several leadership teams across the organization spanning discovery, pre-clinical and clinical research.
Nadeem serves as the Industry Lead for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Genetics Core, sits on the Institute of Medicine (IOM) Genomics Roundtable, coordinates the Industry Partnership for Human Genetics, and has been invited to help advise the World Dementia Envoy and Genomics Enterprise.
Nadeem joined Eisai from Pfizer, where he served as the Head of Population Research & Head of Cardiometabolic Genetics, and helped lead development and initiation of a new Cardiovascular Therapeutic Area Strategy. Prior to working in industry Nadeem was tenured faculty at the University of Cambridge, working with Professor John Danesh, where his research involved coordination of large-scale research consortia and establishment of new genetic and molecular epidemiology bioresources.
Nadeem was born in Aberdeen, Scotland, and enjoys reminiscing about when he used to play rugby, cricket and athletics. He lives in Wellesley, MA (USA) with his wife and two young daughters.